RGC

Conviction 4HealthcareScan · Mon, Aug 10, 2026

RGC$5.36-0.92%

ResistanceSupportVol 14

Vol MA14 194.18K

May 11May 28Jun 16Jul 6Jul 23Aug 10

Regencell Bioscience Holdings LtdDrug Manufacturers - Specialty & Genericwww.regencellbioscience.com ↗

Price5.36

Change-0.92%

Gap+1.66%

Rel volume0.07×

Avg volume233.95K

Avg $ vol1.33M

SMA 205.65

SMA 5010.34

SMA 20020.77

Price vs 50-48.18%

Price vs 200-74.20%

MA stackbearish

50/200 cross—

Supertrenddown · 7.46

RSI (14)33

MACD hist0.39

MACD cross—

Stoch %K / %D10 / 19

ADX (14)29

+DI / −DI16 / 25

RSI divergence—

MACD divergence—

ATR %+15.81%

ADR %10.74%

52w high52.88

52w low4.78

From 52w high-89.86%

Above 52w low+12.13%

New 52w highNo

SqueezeOn · 6d

Bollinger width28.03%

%B0.32

Donchian pos37.95%

Donchian high6.75

Donchian low4.51

AVWAP (52w high)22.82

vs AVWAP high-76.51%

AVWAP (52w low)5.80

vs AVWAP low-7.59%

OBV trendFlat

Chaikin MF (20)0.01

Today vs 20d0.07×

Avg vol (14d)194.18K

Avg vol (20d)233.95K

Avg $ vol (20d)1.33M

Market cap—

RS 3m (vs SPY)-88.51%

RS 6m (vs SPY)-92.53%

RS line new highNo

Trend template1/8

Technical rank13.2

1 week-12.56%

1 month-8.84%

3 months-81.69%

6 months-80.32%

1 year-59.33%

YTD-73.90%

P/E—

P/B550.42

P/S—

P/FCF—

EPS—

Div yield—

ROE—

ROA—

Debt/Eq0.62

Current7.39

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth—

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value2.67B

Revenue—

Net income—

Gross profit—

Free cash flow—

IndustryDrug Manufacturers - Specialty & Generic

ExchangeNasdaq

Shares out494.49M

Employees10

ListedFri, Jul 16, 2021

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction4 / 100

Pattern quality—

Tech rank13.2 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance8.23

Support4.71

Days since event—

Candle confirm—

News sentiment—

Congress activity

Disclosed STOCK Act trades in RGC

All disclosures →

No recent disclosed trades by Congress in RGC. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in RGC · 2 sells

Insider	Side	Shares	Value	Traded	Filed
LO WILLIAM WING YAN DR Director · Stock option (right to purchase) · 2026-05-27	Disposition	70.6K	—	2026-05-27	2026-05-29
HUI EVANA YEE WAH Director · Stock option (right to purchase) · 2026-05-27	Disposition	19K	—	2026-05-27	2026-05-29

SEC filings

EDGAR filings in RGC

EDGAR →

No recent SEC filings on file for RGC.

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.